Loading

Case Report Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.33696/casereports.4.015

Imatinib Induced Hypopigmentation and Neutropenia in a Patient with Gastric Gastrointestinal Stromal Tumor

  • 1MD, Department of Internal Medicine, Northshore University Hospital, 300 Community Drive, Manhasset NY
  • 2MD, Department of Hematology Oncology, Northshore University Hospital, 300 Community Drive, Manhasset NY
  • 3MD, Professor, Department of Hematology Oncology, Northshore University Hospital, 300 Community Drive, Manhasset NY
+ Affiliations - Affiliations

Corresponding Author

Muhammad W Saif, wsaif@northwell.edu

Received Date: March 23, 2021

Accepted Date: July 22, 2021

Abstract

Introduction: Imatinib therapy for gastrointestinal stromal tumors (GIST) rarely can cause pigmentary changes. When associated with sensitive areas such as the face, it can cause significant psychosocial impact and efforts should be made to correct it. Here we describe a case of hypopigmentation affecting the face in an African American female with concurrent development of neutropenia with resolution upon dose reduction of imatinib.

Author Information X